293 related articles for article (PubMed ID: 6884713)
21. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
Richardson CT; Feldman M; Brater C; Welborn J
Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
[TBL] [Abstract][Full Text] [Related]
22. Effect of a new potent H2-blocker, 3-]]]2-[(diaminomethylene)amino]-4-thiazolyl]methyl]-thio]-N2-sulfamoylpropionamidine (YM-11170) on gastric secretion induced by histamine and food in conscious dogs.
Takagi T; Takeda M; Maeno H
Arch Int Pharmacodyn Ther; 1982 Mar; 256(1):49-58. PubMed ID: 6124219
[TBL] [Abstract][Full Text] [Related]
23. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
24. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
25. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of ORF 17578, a new histamine H2-receptor antagonist: comparison with cimetidine and ranitidine.
Katz LB; Scott CK; Shriver DA
J Pharmacol Exp Ther; 1986 May; 237(2):404-10. PubMed ID: 2871172
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
Black EW; Strada SJ; Garrett RL; Kvietys PR; Thompson WJ; Norman JA
J Pharmacol Exp Ther; 1989 Jan; 248(1):208-14. PubMed ID: 2464057
[TBL] [Abstract][Full Text] [Related]
28. Effect of omeprazole on gastric acid secretion and plasma gastrin.
Olbe L; Cederberg C; Lind T; Olausson M
J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Batzri S; Brugada O; Harmon JW; Rich NM
J Pharmacol Exp Ther; 1988 Aug; 246(2):493-9. PubMed ID: 2841448
[TBL] [Abstract][Full Text] [Related]
30. YM022 [(R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl- 1H-1,4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea], a potent and selective gastrin/cholecystokinin-B receptor antagonist, prevents gastric and duodenal lesions in rats.
Nishida A; Takinami Y; Yuki H; Kobayashi A; Akuzawa S; Kamato T; Ito H; Yamano M; Nagakura Y; Miyata K
J Pharmacol Exp Ther; 1994 Sep; 270(3):1256-61. PubMed ID: 7932178
[TBL] [Abstract][Full Text] [Related]
31. Properties of the reversible, K(+)-competitive inhibitor of the gastric (H+/K+)-ATPase, SK&F 97574. II. Pharmacological properties.
Parsons ME; Rushant B; Rasmussen TC; Leach C; Ife RJ; Postius S; Pope AJ
Biochem Pharmacol; 1995 Nov; 50(10):1551-6. PubMed ID: 7503756
[TBL] [Abstract][Full Text] [Related]
32. Antisecretory effects of a novel and long-lasting histamine H2-receptor antagonist, YM-14471, in rats and dogs.
Yuki H; Kamato T; Nishida A; Fujihara A; Takeda M; Miyata K
Jpn J Pharmacol; 1993 Nov; 63(3):345-51. PubMed ID: 7906319
[TBL] [Abstract][Full Text] [Related]
33. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
[TBL] [Abstract][Full Text] [Related]
34. Antisecretory effects of two new histamine H2-receptor antagonists.
Bickel M; Herling AW; Rising TJ; Wirth K
Arzneimittelforschung; 1986 Sep; 36(9):1358-63. PubMed ID: 2878669
[TBL] [Abstract][Full Text] [Related]
35. Antisecretory and antiulcer effects of YM020, a new H+,K(+)-ATPase inhibitor, in rats and dogs.
Yuki H; Kamato T; Nishida A; Ohta M; Shikama H; Yanagisawa I; Miyata K
Jpn J Pharmacol; 1995 Jan; 67(1):59-67. PubMed ID: 7745846
[TBL] [Abstract][Full Text] [Related]
36. Use of a cannula insert in erratic emptying Heidenhain pouch dogs: effect of single and cumulative doses of omeprazole.
Ghelani A; Radziwonik H
Methods Find Exp Clin Pharmacol; 1990 Nov; 12(9):613-8. PubMed ID: 2084455
[TBL] [Abstract][Full Text] [Related]
37. Calcitonin gene-related peptide: potent peripheral inhibitor of gastric acid secretion in rats and dogs.
Taché Y; Pappas T; Lauffenburger M; Goto Y; Walsh JH; Debas H
Gastroenterology; 1984 Aug; 87(2):344-9. PubMed ID: 6145652
[TBL] [Abstract][Full Text] [Related]
38. Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat.
Kato S; Aihara E; Yoshii K; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G64-9. PubMed ID: 15961884
[TBL] [Abstract][Full Text] [Related]
39. The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
Palumbo GJ; Nielsen ST
Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):151-5. PubMed ID: 2898575
[TBL] [Abstract][Full Text] [Related]
40. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
